|
Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) |
|
Sonoma Pharmaceuticals Inc
SNOA's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Sonoma Pharmaceuticals Inc growth rates, revenue grew
by 13.58 % in the third quarter of 2024 from the same quarter a year ago.
Ranking at No. 216
Medical Equipment & Supplies industry recorded
deterioration of revenues by -0.09 %
Sonoma Pharmaceuticals Inc net loss increased from $-1 millions, to $-1 millions in third quarter of 2024,
• More on SNOA's Growth
|
|
Sonoma Pharmaceuticals Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 1.53 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.31.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.07.
• More on SNOA's Valuation
|
|
|
|
|
Sonoma Pharmaceuticals Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 1.53 in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.31.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.07.
Sonoma Pharmaceuticals Inc Price to Book Ratio is at 0.89 higher than Industry Avg. of -500.27, and higher than S&P 500 Avg. of 0.01
• More on SNOA's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com